Arkolith/Insider Trading/PRTK/Form 4

Bigham Michael

Exec. Chairman of the Board, DirectorParatek Pharmaceuticals, Inc. (PRTK) · full profile →Form 4 · filed Dec 14, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$101K
Net Open-Market Flow
-$101K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2022Sell(S)32K$1.96$63K1.2M
Dec 12, 2022Sell(S)19K$1.98$39K1.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000904454-22-000621) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML